Proportions of patients with HIV retained in care and virally suppressed in New York City and the United States: Higher than we thought

Journal of Acquired Immune Deficiency Syndromes

Volumn 68, Issue 3, 2015, Pages 351-358

  Xia, Qiang ^a   Kersanske, Laura S ^a   Wiewel, Ellen W ^a   Braunstein, Sarah L ^a   Shepard, Colin W ^a   Torian, Lucia V ^a  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

HIV; standard of care; statistical weighting; surveillance; viral load

Indexed keywords

ADOLESCENT; ADULT; AGED; AMERICAN INDIAN; ARTICLE; BLACK PERSON; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG USE; ETHNICITY; FEMALE; FOLLOW UP; GROUPS BY AGE; HEALTH CARE UTILIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFANT; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NEWBORN; PRIORITY JOURNAL; RACE; UNITED STATES; VIRUS LOAD; HIV INFECTIONS; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRESCHOOL CHILD; PROCEDURES; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEW YORK CITY; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT COMPLIANCE; UNITED STATES; VIRAL LOAD; YOUNG ADULT;

EID: 84923643564     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000464     Document Type: Article

References (32)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338: 853-860.
2. Marks G, Gardner LI, Craw J, et al. Entry and retention in medical care among HIV-diagnosed persons: a meta-analysis. AIDS. 2010; 24: 2665-2678.
3. Torian LV, Wiewel EW, Liu KL, et al. Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med. 2008; 168: 1181-1187.
4. Molitor F, Kuenneth C, Waltermeyer J, et al. Linking HIV-infected persons of color and injection drug users to HIV medical and other services: the California Bridge Project. AIDS Patient Care STDS. 2005; 19: 406-412.
5. Pollini RA, Blanco E, Crump C, et al. A community-based study of barriers to HIV care initiation. AIDS Patient Care STDS. 2011; 25: 601-609.
6. Hall HI, Frazier EL, Rhodes P, et al. Differences in human immunodeficiency virus care and treatment among subpopulations in the United States. JAMA Intern Med. 2013; 173: 1337-1344.
7. Brown A, Aghaizu A, Murphy G, et al. Predictors for high vireamia among a treatment-naïve national HIV cohort in the United Kingdom (Abstract No. MOAC0201). Proceedings of the 19th International AIDS Conference, July 22-27, 2012. Washington, DC.
8. Supervie V, Costagliola D. The spectrum of engagement in HIV care in France: strengths and gaps (Abstract # 1030). Proceedings of the 20th Conference on Retroviruses and Opportunistic Infections, March 3-6, 2013. Atlanta, GA.
9. UNAIDS. UNAIDS World AIDS Day Report 2012. Geneva, Switzerland; 2012.
10. Massey JT. Design and Estimation for the National Health Interview Survey, 1985-94. Hyattsville, MD: U.S. Dept. of Health and Human Services, Public Health Service, Centers for Disease Control, National Center for Health Statistics; 1989.
11. Lohr SL. Sampling: Design and Analysis. 2nd ed. Boston: Cengage Learning; 2010.
12. Fauci AS, Pantaleo G, Stanley S, et al. Immunopathogenic mechanisms of HIV infection. Ann Intern Med. 1996; 124: 654-663.
13. Xia Q, Nonoyama A, Molitor F, et al. Recent decline in the incidence of human immunodeficiency virus infection among California men who have sex with men. Am J Epidemiol. 2011; 174: 203-210.
14. Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep. 2011; 60: 1618-1623.
15. Dombrowski J, Kent J, Buskin S, et al. An encouraging HIV care cascade: anomaly, progress, or just more accurate data. (Abstract # 1027). Proceedings of the 20th Conference on Retroviruses and Opportunistic Infections, March 3-6, 2013. Atlanta, GA.
16. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol. 2005; 162: 199-200.
17. Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 U.S. dependent areas-2011. HIV Surveillance Supplemental Report. 2013; 18(No. 5): 1-47.
18. Kaiser Family Foundation. Fact sheet: Medicare and HIV/AIDS. 2009. Available at: http: //kff.org/hivaids/fact-sheet/medicare-and-hivaids/. Accessed January 14, 2015.
19. Kaiser Family Foundation. Fact sheet: Medicaid and HIV/AIDS. 2013. Available at: http: //kff.org/hivaids/fact-sheet/medicaid-and-hivaids/. Accessed January 14, 2015.
20. Kaiser Family Foundation. Fact sheet: The Ryan White Program. 2013. Available at: http: //kff.org/hivaids/fact-sheet/the-ryan-white-program/. Accessed January 14, 2015.
21. U.S. Food and Drug Adminstration. Antiretroviral drugs used in the treatment of HIV infection. 2013. Available at: http: //www.fda.gov/ forpatients/illness/hivaids/treatment/ucm118915.htm. Accessed January 14, 2015.
22. Hanna DB, Pfeiffer MR, Sackoff JE, et al. Comparing the national death Index and the Social Security Administration's Death Master File to ascertain death in HIV surveillance. Public Health Rep. 2009; 124: 850-860.
23. Hall HI, Gray KM, Tang T, et al. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr. 2012; 60: 77-82.
24. Benbow N, Scheer S, Wohl A, et al. Linkage, access, ART use and viral suppression in four large cities in the United States, 2009 (Abstract#: MOPDC0303). Proceedings of the 19th International AIDS Conference, July 22-27, 2012. Washington DC.
25. Buskin SE, Kent JB, Dombrowski JC, et al. Migration distorts surveillance estimates of engagement in care: results of public health investigations of persons who appear to be out of HIV care. Sex Transm Dis. 2014; 41: 35-40.
26. McNaghten AD, Wolfe MI, Onorato I, et al. Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: the rationale for developing a population-based approach. PLoS One. 2007; 2: e550.
27. Frankel MR, McNaghten A, Shapiro MF, et al. A probability sample for monitoring the HIV-infected population in care in the U.S. and in selected states. Open AIDS J. 2012; 6: 67-76.
28. Dombrowski JC, Kent JB, Buskin SE, et al. Population-based metrics for the timing of HIV diagnosis, engagement in HIV care, and virologic suppression. AIDS. 2012; 26: 77-86.
29. Saez-Cirion A, Bacchus C, Hocqueloux L, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. Plos Pathog. 2013; 9: e1003211.
30. Udeagu CC, Webster TR, Bocour A, et al. Lost or just not following up: public health effort to re-engage HIV-infected persons lost to follow-up into HIV medical care. AIDS. 2013; 27: 2271-2279.
31. Dombrowski JC, Buskin SE, Bennett A, et al. Use of multiple data sources and individual case investigation to refine surveillance-based estimates of the HIV care continuum. J Acquir Immune Defic Syndr. 2014; 67: 323-330.
32. New York City Department of Health and Mental Hygiene. Advisory #27: DOHMH now recommends offering antiretroviral treatment to any person living with HIV, regardless of the person's CD4 cell count. New York, NY; 2011